Who Owns the Ocean’s Genes? Tension on the High Seas
By Olive Heffernan,
Scientific American
| 09. 12. 2022
Tavis Beck on Unsplash
After nearly two weeks of recent United Nations negotiations in New York City, countries from around the world failed to finalize an ambitious treaty that would create enormous marine protected areas and enforce stricter rules for industry on the high seas—the two thirds of the ocean beyond any country’s exclusive ocean territory. The deal faltered in the final hours, mainly over an issue that has long dogged international ocean talks: how to share profits from commercializing the high seas’ genetic resources.
Ocean organisms, both plants and animals, form the basis of numerous successful drugs, including remdesivir, the first treatment approved for COVID, and Halaven, a blockbuster anticancer drug derived from a Japanese sea sponge that has annual sales of more than $300 million. Genetic material from high seas organisms and the digital data from sequencing their genomes could be used to develop new products potentially worth billions of dollars. But who owns these resources, which theoretically belong to the entire world, and who gets to profit from their use? The details of where U.N. negotiators...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...